{"nctId":"NCT05967442","briefTitle":"Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines","startDateStruct":{"date":"2019-08-23","type":"ACTUAL"},"conditions":["Migraine","Headache"],"count":157,"armGroups":[{"label":"Magnesium","type":"EXPERIMENTAL","interventionNames":["Drug: Magnesium Sulfate"]},{"label":"Metoclopramide","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Metoclopramide 10mg"]},{"label":"Prochlorperazine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Prochlorperazine (Compazine) Injection"]}],"interventions":[{"name":"Magnesium Sulfate","otherNames":[]},{"name":"Metoclopramide 10mg","otherNames":[]},{"name":"Prochlorperazine (Compazine) Injection","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\> 18 years or older\n* Able to provide informed consent\n* Primary diagnosis of headache or migraine\n* Between October 1, 2018 to April 1, 2020\n* Presenting to Advocate Christ Medical Center emergency department and meet clinical assessment per physician\n\nExclusion Criteria:\n\n* Pregnancy defined as a positive urine HCG\n* Stated history of renal impairment\n* Allergy or sensitivity to any study drugs\n* Concomitant treatment at the time of study drug administered in the emergency department\n* Patients with a history of this study participation","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"30 Minute Pain Score","description":"Scores range from 0-10. A higher score, denotes more pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Stay","description":"Emergency Department Length of stay. Measured from time of arrival to time of discharged documented in the electronic medical record.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"325","spread":null},{"groupId":"OG001","value":"308","spread":null},{"groupId":"OG002","value":"332","spread":null}]}]}]},{"type":"SECONDARY","title":"Need for Rescue Analgesia","description":"Percentage of participants who had necessity for rescue analgesics after study drug administration","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26","spread":null},{"groupId":"OG001","value":"15","spread":null},{"groupId":"OG002","value":"17","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":61},"commonTop":[]}}}